Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Rice wins award to recruit cancer researcher: $2 million CPRIT grant aims to bring MIT researcher Omid Veiseh to Houston

Omid VeisehImage courtesy of O. Veiseh
Omid Veiseh

Image courtesy of O. Veiseh

Abstract:
Rice University has won a $2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to recruit biomaterials researcher and entrepreneur Omid Veiseh to Rice's Department of Bioengineering.

Rice wins award to recruit cancer researcher: $2 million CPRIT grant aims to bring MIT researcher Omid Veiseh to Houston

Houston, TX | Posted on June 7th, 2016

The grant is one of 35 totaling nearly $80 million announced by the publicly funded CPRIT last month.

Veiseh, who just finished a postdoctoral research fellowship in the lab of MIT biomedical engineer Robert Langer, specializes in the development of biomaterials for drug delivery and tissue-engineering applications and is an inventor on 12 pending or awarded patents.

Veiseh said he plans to join Rice's bioengineering faculty in July 2017 and looks forward to establishing his laboratory in the BioScience Research Collaborative.

"I'm looking forward to collaborating with a number of different folks at the Texas Medical Center complex, including people from Baylor College of Medicine, Houston Methodist, the UT Health Science Center at Houston and Texas Children's Hospital," Veiseh said. "Rice is a fantastic institution, and the Department of Bioengineering is highly ranked with world renowned faculty and outstanding students. Those things and the proximity to the Texas Medical Center were a very attractive combination."

Veiseh said he will spend the next year working at Sigilon Inc., a biomaterials startup he co-founded in Cambridge, Mass.

"We have a platform technology that allows us to modulate immune responses to implanted materials," he said. "There's a wide array of applications that we can tackle, from implantable devices to cell-based therapies and regenerative medicine. It's fairly early stage, and that is why I needed a year to focus on it before I start my own lab."

Veiseh said his laboratory will specialize in developing next-generation biomaterials for cancer, regenerative medicine and other applications.

"The goal is to develop technologies that can have a meaningful impact on human health," he said. "The focus will be on developing materials, and there will be a synthetic biology component. The materials will allow us to localize therapies to various parts of the body. They're carriers for drugs, but they can also carry imaging agents that are accessible by MRI, such as magnetic nanoparticles, or imaging agents that are detectable through fluorescence imaging."

He said one area of concentration will be on understanding the pathology of diseases such as cancer to identify targets that are reliable, prognostic indicators. "The engineering aspect will focus on facilitating interaction with those targets through the use of proteins, peptides, antibodies or small molecules," he said.

Prior to joining MIT in 2011, Veiseh earned a bachelor's degree in cell biology at Western Washington University and a dual Ph.D. in materials science and engineering and in nanotechnology from the University of Washington.

In late May, CPRIT awarded six research grants to support the recruitment of promising emerging cancer scientists to academic institutions in Texas. To date, CPRIT has awarded 1,033 grants totaling more than $1.57 billion. The agency was launched in 2009 after Texas voters overwhelmingly approved a 2007 bond issue committing $3 billion to the fight against cancer.

####

About Rice University
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,910 undergraduates and 2,809 graduate students, Rice’s undergraduate student-to-faculty ratio is 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for best quality of life and for lots of race/class interaction by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance. To read “What they’re saying about Rice,” go to tinyurl.com/RiceUniversityoverview.

Follow Rice News and Media Relations on Twitter @RiceUNews.

For more information, please click here

Contacts:
Jade Boyd
713-348-6778

Copyright © Rice University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Cancer

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project